110 related articles for article (PubMed ID: 7427899)
41. [Assessment the efficacy of postoperative radiotherapy in the patients with non-small cell lung cancer. Retrospective study].
Chmielewska E; Jodkiewicz Z; Karwański M
Pneumonol Alergol Pol; 2012; 80(2):109-19. PubMed ID: 22370979
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of short-course preoperative irradiation in the treatment of resectable bronchus carcinoma: long-term analysis of a randomized pilot-study.
Kazem I; Jongerius CM; Lacquet LK; Kramer G; Huygen PL
Int J Radiat Oncol Biol Phys; 1984 Jul; 10(7):981-5. PubMed ID: 6378851
[TBL] [Abstract][Full Text] [Related]
43. Single-dose half-body irradiation for palliation of multiple bone metastases from solid tumors. Final Radiation Therapy Oncology Group report.
Salazar OM; Rubin P; Hendrickson FR; Komaki R; Poulter C; Newall J; Asbell SO; Mohiuddin M; Van Ess J
Cancer; 1986 Jul; 58(1):29-36. PubMed ID: 2423225
[TBL] [Abstract][Full Text] [Related]
44. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
[TBL] [Abstract][Full Text] [Related]
45. Preoperative concurrent radiation therapy and cisplatinum continuous infusion in IIIa (N2) non small cell lung cancer. A pilot study.
Maggi G; Casadio C; Cianci R; Oliaro A; Molinatti M; Bretti S; Clerico M; Boidi-Trotti A; Rovea P
J Cardiovasc Surg (Torino); 1994 Aug; 35(4):341-6. PubMed ID: 7929550
[TBL] [Abstract][Full Text] [Related]
46. [The value of radiotherapy for liver metastases].
Eble MJ; Gademann G; Wannenmacher M
Strahlenther Onkol; 1993 Aug; 169(8):459-68. PubMed ID: 7689254
[TBL] [Abstract][Full Text] [Related]
47. Neoadjuvant cisplatin plus vinblastine chemotherapy in locally advanced non-small cell lung cancer.
Johnson DH; Strupp J; Greco FA; Stewart J; Merrill W; Malcolm A; Hande KR; Hainsworth JD
Cancer; 1991 Sep; 68(6):1216-20. PubMed ID: 1651802
[TBL] [Abstract][Full Text] [Related]
48. [Hyperfractionated irradiation of non-small cell bronchial cancer. Final results of a Phase II study].
Berberich W; Bier B; Schnabel K; Schlimmer P
Strahlenther Onkol; 1993 Aug; 169(8):469-75. PubMed ID: 8395087
[TBL] [Abstract][Full Text] [Related]
49. [Treatment of inoperable small-cell bronchial carcinoma with local radiotherapy and supplementary high-dosage one-time upper and lower half-body irradiation].
Hüttner J; Eichhorn HJ; Dallüge KH; Grunau H
Arch Geschwulstforsch; 1984; 54(3):239-42. PubMed ID: 6087768
[TBL] [Abstract][Full Text] [Related]
50. Prognostic indicators in stage III and localized stage IV breast cancer.
Rao DV; Bedwinek J; Perez C; Lee J; Fineberg B
Cancer; 1982 Nov; 50(10):2037-43. PubMed ID: 7127248
[TBL] [Abstract][Full Text] [Related]
51. From conventionally fractionated radiation therapy to hyperfractionated radiation therapy alone and with concurrent chemotherapy in patients with early-stage nonsmall cell lung cancer.
Jeremić B; Milicić B
Cancer; 2008 Feb; 112(4):876-84. PubMed ID: 18172901
[TBL] [Abstract][Full Text] [Related]
52. [Endoluminal HDR brachytherapy in the palliative treatment of patients with the recurrence of a non-small-cell bronchial carcinoma after prior radiotherapy].
Micke O; Prott FJ; Schäfer U; Wagner W; Pötter R; Willich N
Strahlenther Onkol; 1995 Oct; 171(10):554-9. PubMed ID: 8571174
[TBL] [Abstract][Full Text] [Related]
53. A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer.
Feigenberg SJ; Hanlon AL; Langer C; Goldberg M; Nicolaou N; Millenson M; Coia LR; Lanciano R; Movsas B
J Thorac Oncol; 2007 Apr; 2(4):287-92. PubMed ID: 17409799
[TBL] [Abstract][Full Text] [Related]
54. Prophylactic irradiation in bronchogenic small cell anaplastic carcinoma. A comparative trial of localized versus extensive radiotherapy including prophylactic brain irradiation in patients receiving combination chemotherapy.
Hansen HH; Dombernowsky P; Hirsch FR; Hansen M; Rygård J
Cancer; 1980 Jul; 46(2):279-84. PubMed ID: 6992979
[TBL] [Abstract][Full Text] [Related]
55. Irinotecan and cisplatin with concurrent split-course radiotherapy in locally advanced nonsmall-cell lung cancer: a multiinstitutional phase 2 study.
Fukuda M; Soda H; Fukuda M; Kinoshita A; Nakamura Y; Nagashima S; Takatani H; Tsukamoto K; Kohno S; Oka M
Cancer; 2007 Aug; 110(3):606-13. PubMed ID: 17577234
[TBL] [Abstract][Full Text] [Related]
56. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
[TBL] [Abstract][Full Text] [Related]
57. Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: a European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study.
Gregor A; Drings P; Burghouts J; Postmus PE; Morgan D; Sahmoud T; Kirkpatrick A; Dalesio O; Giaccone G
J Clin Oncol; 1997 Aug; 15(8):2840-9. PubMed ID: 9256127
[TBL] [Abstract][Full Text] [Related]
58. Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer.
Hasselle MD; Haraf DJ; Rusthoven KE; Golden DW; Salgia R; Villaflor VM; Shah N; Hoffman PC; Chmura SJ; Connell PP; Vokes EE; Weichselbaum RR; Salama JK
J Thorac Oncol; 2012 Feb; 7(2):376-81. PubMed ID: 22198429
[TBL] [Abstract][Full Text] [Related]
59. Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach.
Newman SB; DeMeester TR; Golomb HM; Hoffman PC; Little AG; Raghavan V
J Thorac Cardiovasc Surg; 1983 Aug; 86(2):180-5. PubMed ID: 6308356
[TBL] [Abstract][Full Text] [Related]
60. [Treatment outcome of locally advanced stage IIIA/B lung cancer].
Cicenas S; Zaliene A; Atkocius V
Medicina (Kaunas); 2009; 45(6):452-9. PubMed ID: 19605965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
